Showing 1 to 1 of 1 results
cnbc.com
🌐 75% Global Worthiness
VRTX Stock Surges on Positive Casgevy Data and Analyst Upgrades
Vertex Pharmaceuticals (VRTX) stock price is surging due to positive long-term data for its gene therapy Casgevy and several bullish analyst upgrades, with Jefferies raising its price target to $550.00.
VRTX Stock Surges on Positive Casgevy Data and Analyst Upgrades
Vertex Pharmaceuticals (VRTX) stock price is surging due to positive long-term data for its gene therapy Casgevy and several bullish analyst upgrades, with Jefferies raising its price target to $550.00.
Progress
52% Bias Score
No Poverty
Showing 1 to 1 of 1 results